Related Experiment Video

Updated: Jun 27, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Reactivation of p53 function in synovial sarcoma cells by inhibition of p53-HDM2 interaction

Pádraig D'Arcy1, Bríd Ann Ryan, Bertha Brodin

  • 1Department of Oncology-Pathology, Cancer Center Karolinska, Karolinska Institute, Stockholm, Sweden.

Cancer Letters
|December 17, 2008
PubMed

Insights

HDM2 antagonist nutlin-3 activates tumor suppressor p53 in synovial sarcoma cells, inducing apoptosis. Aberrant HDM2 activity suppresses p53, suggesting targeting the p53-HDM2 axis for cancer therapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • Synovial sarcoma is a rare soft tissue sarcoma.
  • Mutations in the p53 tumor suppressor gene are infrequent in synovial sarcoma.
  • The HDM2 protein negatively regulates p53 activity.

Purpose of the Study:

  • To investigate the efficacy of the HDM2 antagonist nutlin-3 in activating p53 in synovial sarcoma cell lines.
  • To explore the role of the p53-HDM2 interaction in regulating p53 activity in this cancer type.

Main Methods:

  • Treatment of synovial sarcoma cell lines with nutlin-3 and doxorubicin.
  • Assessment of p53 stability and transcriptional activity.
  • Analysis of p53-HDM2 complex formation using co-immunoprecipitation.

Main Results:

  • Nutlin-3 treatment stabilized p53 and activated p53 target genes, leading to growth arrest and apoptosis.
  • Synovial sarcoma cells showed p53 stabilization upon DNA damage but abrogated transcriptional activation.
  • High levels of p53-HDM2 complexes were observed in doxorubicin-treated cells, correlating with suppressed p53 activity.

Conclusions:

  • p53 function is suppressed by aberrant HDM2 activity in synovial sarcoma.
  • Targeting the p53-HDM2 regulatory axis presents a potential therapeutic strategy for synovial sarcoma.

More Related Videos

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay05:17

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...